Management of Hepatitis C in Special Populations: HIV Coinfection, Renal Disease, and Decompensated Cirrhosis-Reference-Cited by-同舟云学术

Management of Hepatitis C in Special Populations: HIV Coinfection, Renal Disease, and Decompensated Cirrhosis

Published:2020-07 Issue:1 Volume:16 Page:29-31
ISSN:2046-2484
Container-title:Clinical Liver Disease
language:en
Short-container-title:Clinical Liver Disease

Author:

Lim Joseph K.¹^ORCID

Affiliation:

1. Yale Liver Center Section of Digestive Diseases Yale University School of Medicine New Haven CT

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.965

Reference10 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016

3. Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges

4. Hepatic decompensation in antiretroviral‐treated patients co‐infected with HIV and hepatitis C virus compared with hepatitis C virus‐monoinfected patients: a cohort study;Lo Re V;Ann Intern Med,2014

5. American Association for the Study of Liver Diseases and Infectious Diseases Society of America.HCV guidance: recommendations for testing managing and treating hepatitis C. Available at:https://www.hcvguidelines.org. Accessed February 12 2020.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions;The Lancet Gastroenterology & Hepatology;2024-04

2. Chronic Hepatitis C Virus Infection: An Ongoing Challenge in Screening and Treatment;Life;2023-09-26

3. Substance use disparities by age, race, sex, and sexual orientation among persons living with HIV in the Southern U.S.;International Journal of STD & AIDS;2023-03-15

4. Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs): A Qualitative Analysis with Persons with HIV/HCV Co-infection Who Delay or Refuse Treatment;AIDS and Behavior;2022-07-01

5. An update on direct antiviral agents for the treatment of hepatitis C;Expert Opinion on Pharmacotherapy;2021-05-11